D-0497-2023 Class II Terminated
FDA drug recall D-0497-2023 was initiated by RemedyRepack Inc. on Mar 20, 2023 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Oct 19, 2023). Affected quantity: 16 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 12, 2023
- Initiation Date
- Mar 20, 2023
- Termination Date
- Oct 19, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 16 bottles
Product description
Tadalafil 5 mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2972-00
Reason for recall
cGMP Deviations
Distribution pattern
RemedyRepack distributed product to consignees nationwide within the United States
Code information
Lot #: B1635780-040522, Exp. Date 04/30/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0497-2023
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026